Correction: Natriuretic peptide signaling as a therapeutic target in POTS: physiological opportunities and caveats

Key Result

The authors published a correction to fix the wrong code name for an experimental drug discussed in the original manuscript regarding natriuretic peptide signaling in POTS.

Key Points

• This study aims to explore the role of natriuretic peptide signaling in the treatment of postural orthostatic tachycardia syndrome (POTS).
• Reviewed existing literature on natriuretic peptides and their signaling mechanisms in relation to POTS.
• Analyzed physiological responses associated with natriuretic peptide therapies.
• Discussed caveats and considerations for therapeutic applications in clinical settings.
• Identified potential benefits of targeting natriuretic peptides in POTS management.
• Highlighted risks and challenges associated with natriuretic peptide therapies.
• Recommended further investigation into specific interventions and outcomes.